Fig. 3
Kaplan–Meier curves of cancer-specific survival comparison in patients treated with RARC versus LRC. 5-years-CSS = (RARC: 73.318%, LRC: 61.554%); P = 0.6143; HR = 0.7891; 95CI = (0.4112 to 1.515)
Fig. 3 | BMC Surgery
Kaplan–Meier curves of cancer-specific survival comparison in patients treated with RARC versus LRC. 5-years-CSS = (RARC: 73.318%, LRC: 61.554%); P = 0.6143; HR = 0.7891; 95CI = (0.4112 to 1.515)